Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
AstraZeneca
US Army
QuintilesIMS
Fish and Richardson
Healthtrust
McKesson
Moodys
McKinsey
Express Scripts

Generated: August 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204153

« Back to Dashboard
NDA 204153 describes LUZU, which is a drug marketed by Medicis and is included in one NDA. It is available from one supplier. There are five patents protecting this drug. Additional details are available on the LUZU profile page.

The generic ingredient in LUZU is luliconazole. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the luliconazole profile page.

Summary for NDA: 204153

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:5

Pharmacology for NDA: 204153

Ingredient-typeAzoles
Mechanism of ActionCytochrome P450 2C19 Inhibitors

Suppliers and Packaging for NDA: 204153

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LUZU
luliconazole
CREAM;TOPICAL 204153 NDA Valeant Pharmaceuticals North America LLC 99207-850 99207-850-02 12 TUBE in 1 CARTON (99207-850-02) > 2 g in 1 TUBE
LUZU
luliconazole
CREAM;TOPICAL 204153 NDA Valeant Pharmaceuticals North America LLC 99207-850 99207-850-60 1 TUBE in 1 CARTON (99207-850-60) > 60 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength1%
Approval Date:Nov 14, 2013TE:RLD:Yes
Patent:► SubscribePatent Expiration:Jul 5, 2018Product Flag?YSubstance Flag?YDelist Request?
Patent:► SubscribePatent Expiration:Apr 28, 2034Product Flag?YSubstance Flag?Delist Request?
Patent:► SubscribePatent Expiration:Sep 6, 2033Product Flag?YSubstance Flag?YDelist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
QuintilesIMS
Chubb
AstraZeneca
Cipla
Covington
Queensland Health
Deloitte
Moodys
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot